Mike Weinstein

Mr. Weinstein is a Managing Director at JP Morgan Chase & Co., where he heads the firm’s #1 ranked Healthcare group within Equity Research. Mr. Weinstein is a 12-time #1 ranked analyst in the annual surveys of both Institutional Investor and Greenwich Associates, and in 2013 he was named to the Institutional Investor Hall of Fame. Mr. Weinstein has led IPOs for a long list of leading medical technology companies: from Guidant, Alcon, and Zimmer to most recently Glaukos, Nevro, and ConforMIS. Mr. Weinstein joined J.P. Morgan in 1992 and has been the firm’s senior medical technology analyst since 1995.